Rada Savic

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women”.

Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women

Clinical Infectious Diseases(2021)10.1093/cid/ciab665

N/A

0.972DataRank · unranked

34 citations

Rada Savic, Paula Britto, Priya Jayachandran, Lubbe Wiesner, Grace Montepiedra +15 more

Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis

Journal of Antimicrobial Chemotherapy(2020)10.1093/jac/dkaa490

N/A

0.854DataRank · unranked

21 citations

Jon Gelfond, Teresa L. Johnson‐Pais, Melissa Engle, John L. Johnson, William C. Whitworth +8 more

Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)

Clinical Infectious Diseases(2022)10.1093/cid/ciac707

N/A

0.726DataRank · unranked

13 citations

Patrick Phillips, Ekaterina V. Kurbatova, Andrew Vernon, Payam Nahid, Rodney Dawson +17 more

Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children

Nature Communications(2021)10.1038/s41467-021-27051-8

N/A

0.636DataRank · unranked

19 citations

Ali M. Ali, Emma Hughes, Abel Kakuru, Prasanna Jagannathan, Mary Muhindo +11 more

Twice-Daily Dolutegravir–Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention

Clinical Infectious Diseases(2024)10.1093/cid/ciae183

N/A

0.372DataRank · unranked

6 citations

Yoninah Cramer, Marjorie Z. Imperial, Susan L. Rosenkranz, Anchalee Avihingsanon, Roberto C. Arduino +7 more

Reproducibility of the Ribosomal RNA Synthesis Ratio in Sputum and Association with Markers of Mycobacterium tuberculosis Burden

Microbiology Spectrum(2021)10.1128/spectrum.00481-21

N/A

0DataRank · unranked

10 citations

Christian Dide-Agossou, Reem Al Mubarak, Karen Rossmassler, Abdul Wahab Ssesolo, Sylvia Kaswabuli +12 more

Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments

Antimicrobial Agents and Chemotherapy(2022)10.1128/aac.02310-21

N/A

0DataRank · unranked

26 citations

Allison Bauman, Michelle E. Ramey, Karen Rossmassler, Reem Al Mubarak, Samantha Pauly +10 more

Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation

Pharmaceutics(2022)10.3390/pharmaceutics14112462

N/A

0DataRank · unranked

14 citations

Belén P. Solans, Ying Lü, Sandhya Kharbanda, Christopher C. Dvorak, Nahal Lalefar +10 more

MOVER approximated CV: A tool for quantifying precision in ratiometric droplet digital PCR assays

Journal of Pharmaceutical and Biomedical Analysis(2022)10.1016/j.jpba.2022.114664

N/A

0DataRank · unranked

2 citations

Karen Rossmassler, Justin J. Reid, J. R. Purohit, Rada Savic, Payam Nahid +4 more

Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs

European Respiratory Journal(2023)10.1183/13993003.00165-2023

N/A

0DataRank · unranked

16 citations

Janice Jia Ni Goh, Natasha Strydom, Qianwen Wang, Rob C. van Wijk, Nan Zhang +4 more

QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.01448-22

N/A

0DataRank · unranked

10 citations

Kendra K. Radtke, Anneke C. Hesseling, Jana Winckler, H. Simon Schaaf, Heather R. Draper +8 more

Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.18.524608

N/A

0DataRank · unranked

2 citations

Janice Jia Ni Goh, Natasha Strydom, Qianwen Wang, Rob C. van Wijk, Nan Zhang +4 more

Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity

Blood Advances(2024)10.1182/bloodadvances.2024013275

N/A

0DataRank · unranked

12 citations

Moises Garcia-Rosa, Arief Lalmohamed, Tayfun Güngör, Mathias Hauri‐Hohl, Susan E. Prockop +33 more

Desmopressin dosing in children using real-world data and pharmacokinetic/pharmacodynamic model simulations

Pediatric Research(2024)10.1038/s41390-024-03642-1

N/A

0DataRank · unranked

2 citations

Emma Hughes, Rada Savic, Shylaja Srinivasan, Kevin Yen

Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data

iScience(2025)10.1016/j.isci.2025.111932

N/A

0DataRank · unranked

4 citations

Anu Patel, Bernard Ngara, Rob C. van Wijk, Natasha Strydom, Qianwen Wang +9 more

Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis

Pharmacogenetics and Genomics(2025)10.1097/fpc.0000000000000562

N/A

0DataRank · unranked

3 citations

Anne F. Luetkemeyer, Marjorie Z. Imperial, Rodney Dawson, Yoninah Cramer, Sue Rosenkranz +10 more

Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01727-19

N/A

0DataRank · unranked

32 citations

Natasha Strydom, Sandeep Tyagi, Heena Soni, Rokeya Tasneen, Eric L. Nuermberger +2 more

Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108075

N/A

0DataRank · unranked

0 citations

Kelly E. Dooley, Wendy Carr, Jason E. Stout, Eric Nuermberger, Patrick Phillips +22 more

Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis

The Annual Review of Pharmacology and Toxicology(2020)10.1146/annurev-pharmtox-030920-011143

N/A

0DataRank · unranked

48 citations

Natasha Strydom, Qianwen Wang, Nan Zhang, Eric L. Nuermberger, Véronique Dartois +2 more

Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa016

N/A

0DataRank · unranked

25 citations

Amelia N. Deitchman, Si-Yang Li, Kala Barnes-Boyle, Sandeep Tyagi, Heena Soni +4 more

Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children

European Respiratory Journal(2020)10.1183/13993003.01756-2020

N/A

0DataRank · unranked

8 citations

Jennifer Hibma, Anneke C. Hesseling, Rada Savic, Kendra K. Radtke

Visualizing the dynamics of tuberculosis pathology using molecular imaging

Journal of Clinical Investigation(2021)10.1172/jci145107

N/A

0DataRank · unranked

31 citations

Elizabeth W. Tucker, Carolyn J. Anderson, Claire L. Carter, Shashank Ganatra, Deepak Kaushal +13 more